PF-AtlasDrugs › BAL

BAL

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
Centre Hospitalier Universitaire de Saint Etienne

Overview

BAL is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

BAL clinical trials

Explore related

Medical disclaimer. This page summarizes research about BAL for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.